tiprankstipranks
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Financial Statements

28 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently ―. The company's EPS TTM is $-0.922; its P/E ratio is -2.46; bioAffinity Technologies, Inc. is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 2.21M$ 298.48K$ 19.74K$ 921.00-
Gross Profit$ 2.29M$ 223.78K$ 18.50K$ 834.00-
EBIT-$ -2.28M$ -1.73M$ -1.52M-
EBITDA-$ -2.22M$ -1.71M$ -1.50M-
Net Income Common Stockholders$ -2.37M$ -2.08M$ -1.74M$ 1.57M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.80M$ 4.50M$ 8.30M$ 9.80M$ 11.40M
Total Assets$ 8.22M$ 10.19M$ 8.89M$ 10.50M$ 12.18M
Total Debt$ 1.58M$ 1.69M$ 42.33K$ 168.43K$ 251.75K
Net Debt$ -1.22M$ -2.81M$ -8.26M$ -9.63M$ -11.15M
Total Liabilities$ 3.37M$ 3.20M$ 775.15K$ 796.30K$ 1.14M
Stockholders Equity$ 4.86M$ 6.99M$ 8.14M$ 9.67M$ 11.04M
Cash Flow-
Free Cash Flow-$ -1.53M$ -1.36M$ -1.56M$ -1.52M
Operating Cash Flow$ -1.62M$ -1.53M$ -1.36M$ -1.53M$ -1.30M
Investing Cash Flow$ 13.44K$ -2.19M$ -3.86K$ -32.31K$ -219.99K
Financing Cash Flow$ -84.81K$ -50.77K$ -126.10K$ -83.32K$ -563.56K
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

bioAffinity Technologies, Inc. Debt to Assets

bioAffinity Technologies, Inc. Cash Flow

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis